| Tag | Content |
|---|
EnhancerAtlas ID | HS095-01818 |
Organism | Homo sapiens |
Tissue/cell | HMEC |
Coordinate | chr1:118199420-118200270 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:118199687-118199705 | CCTTCCTTCCTTTATTCA | - | 6.63 | | STAT3 | MA0144.2 | chr1:118199880-118199891 | CTTCCCAGAAG | - | 6.14 |
|
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_10504 | chr1:118194357-118199851 | CD19_Primary | | SE_11059 | chr1:118192676-118211584 | CD20 | | SE_43509 | chr1:118193426-118209281 | MM1S | | SE_61007 | chr1:118138819-118218057 | HBL1 | | SE_62427 | chr1:118147317-118217904 | Tonsil | | SE_67143 | chr1:118193426-118209281 | MM1S |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I117651 | chr1 | 118194205 | 118200237 |
|
Enhancer Sequence | CGTGAGCATG GTTCAGTACA GCTTTAGTTC ATGAGCTGTT GTTTGCCCAT TCCGATGTTC 60
TAGAAGAATG CTGGGGATTT GAAATGCTGA AATTTTCGAA TGCTGAAAAT CCATTCGAGC 120
AGATTTTTAT TTGATTCTGC TCTTTATGGG ACAGAAGACA AGTCTGTTTG GGAAGGCATG 180
TGTTTGAAAA GAGCCTAAAG GTGTCTGACC ATTGAGACCC TAGTGCCTAA AAATCTGGAA 240
GAGACTGCCT AGTTCTCAGG GAATGTTCCT TCCTTCCTTT ATTCATTCAT AGACTAGTTT 300
GGAACACCCG CCATGTGACA GGCATCGTGT TGAGCCTTGG TGAGACAGAC AGGCAAGTCT 360
TTGCAGAGCT TATAGCTCAG TTACTGCTGG GGCTGCCAAT GTGATGACTA ATAGCAAAGA 420
GTGTAAAGAA GGACACGACT TAGTTGGGGG CTGGGGAAGA CTTCCCAGAA GAAGCAATGG 480
GTAAGCTGAT TCCCCTGACT GGGAATCCAA GTGAGGGCAG AGACAAGGTA CAGTGTAATC 540
AATGCAGGGA AAGAAACATC AGGTGACAGG CTTTTACATG CCATTTTTAG AGAATATGTG 600
CACTGCTGTA TTGACCCTTT TGGGAGGGTC TGATTCTTTT AGACAACAGG AACATCCGCT 660
TTTCCCACTG GCAGATGGAT CAGGCTGTTG ATCCTGTTCT GTGATCCAAA TGGCTCAGTC 720
TCCATACTGG GAGATGGGGA AGGTATAGCT GATGTTTTGT GTGAGTCGGT GAATTGTCAC 780
AGAAGTAGAC AAAACCATGC AAAATTTCCA TTTGTTTCTT TGGATTTACC TCTGAGCCGA 840
GTCTCTCAGA 850
|
